background high burden respiratory syncyti virus rsvassoci morbid mortal make vaccine develop priority method part efficacy trial tandem influenza vaccine not rev epidemiology health child age month year first vaccine influenzalik ill ili value australia brazil colombia costa rica mexico philippine singapore thailand february august active survey conduct approx year nasal throat swap analyze polymerase chain reaction prevail rcid among episode call result total include experience sample avail detect config inter highest country except per personyear py lightweight result host assoc result medic attend b subtype observe frequent concur demons consider would identify hospitals substantial occur older infant 